急性ST段抬高心肌梗死溶栓治疗的中国专家共识(修订版)

[1] 中国多省市急性冠状动脉综合征住院患者治疗现状与指南差距分析 [J]. 中华心血管病杂志, 2005, (09) : 18 - 21

[2] 中国ST段抬高的急性心肌梗死临床特征及治疗现状 [J]. 中华医学杂志, 2005, (31) : 2176 - 2182

[3] Clinical Trials Update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY[J] . A. Recio-Mayoral,J.-C. Kaski,J. J. V. McMurray,J. Horowitz,D. J. Veldhuisen,W. J. Remme.Cardiovascular Drugs and Therapy . 2007 (6)

[4] Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study) [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) : 417 - 424

[5] Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial[J] . The Lancet . 2005 (9497)

[6] A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: The TUCC trial[J] . Allan M. Ross,Runlin Gao,Karin S. Coyne,Jilin Chen,Kangbao Yao,Yuejin Yang,Xuewen Qin,Shubin Qiao,Min Yao.American Heart Journal . 2001 (2)

[7] Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial[J] . The Lancet . 2001 (9272)

[8] Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction[J] . The Lancet . 2001 (9282)

[9] Fibrinolysis for Acute Myocardial Infarction: Current Status and New Horizons for Pharmacological Reperfusion, Part 1[J] . Paul W. Armstrong,Désiré Collen.Circulation: Journal of the American Heart Association . 2001 (23)

[1] 中国多省市急性冠状动脉综合征住院患者治疗现状与指南差距分析 [J]. 中华心血管病杂志, 2005, (09) : 18 - 21

[2] 中国ST段抬高的急性心肌梗死临床特征及治疗现状 [J]. 中华医学杂志, 2005, (31) : 2176 - 2182

[3] Clinical Trials Update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY[J] . A. Recio-Mayoral,J.-C. Kaski,J. J. V. McMurray,J. Horowitz,D. J. Veldhuisen,W. J. Remme.Cardiovascular Drugs and Therapy . 2007 (6)

[4] Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study) [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) : 417 - 424

[5] Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial[J] . The Lancet . 2005 (9497)

[6] A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: The TUCC trial[J] . Allan M. Ross,Runlin Gao,Karin S. Coyne,Jilin Chen,Kangbao Yao,Yuejin Yang,Xuewen Qin,Shubin Qiao,Min Yao.American Heart Journal . 2001 (2)

[7] Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial[J] . The Lancet . 2001 (9272)

[8] Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction[J] . The Lancet . 2001 (9282)

[9] Fibrinolysis for Acute Myocardial Infarction: Current Status and New Horizons for Pharmacological Reperfusion, Part 1[J] . Paul W. Armstrong,Désiré Collen.Circulation: Journal of the American Heart Association . 2001 (23)